Contact PI/Project LeaderHARLEY, BRENDAN A. Other PIs
Awardee OrganizationUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
Description
Abstract Text
ABSTRACT
Endometriosis is a multifactorial estrogen-dependent disease that affects 10% of all menstruating people.
Endometriotic lesions occur throughout the peritoneal cavity and on the ovaries, leading to chronic pelvic pain
and infertility. Clinical management focuses on surgical resection but improved care is severely limited by our
poor understanding of processes driving lesion formation, persistence, and recurrence. While ovarian
endometriosis lesions (endometriomas) are the most common, essential studies of lesion initiation and growth
are largely intractable in vivo. There is a critical need for experimental tools to investigate processes that shape
endometrioma lesion formation, treatment, and recurrence. The long-term goal of this research program is to
develop a tissue engineering model of the endometrioma lesion microenvironment to study processes that shape
shape lesion initiation, ovarian stroma invasion, and eventual persistence in a chronic inflammatory tissue
microenvironment. Retrograde transport of endometrial tissue and menstrual effluent containing endometrial
epithelial and stromal cells through the fallopian tubes into the peritoneal cavity is believed to contribute to lesion
initiation. However, while the majority of menstruating people experience retrograde menstruation, only a subset
develop endometriosis. Further, lesions are not ubiquitously spread through the peritoneal cavity and on the
ovaries in each patient. Hence, while retrograde menstruation is likely necessary, it is not sufficient: lesion
initiation must be triggered by more than just the presence of these cells. We focus on uncovering multicellular
interactions that shape endometrioma lesion initiation and invasion that may explain the idiosyncratic nature of
lesion distribution. We hypothesize tissue tropism associated with the ovarian microenvironment provides cues
that influence the activity of multicellular cohorts of endometriotic epithelial and stromal cells responsible for
lesion initiation. And subsequently, angiocrine signals from the underlying ovarian perivascular environment
accelerate lesion invasion. The objective of this project it to demonstrate a physiomimetic model of the
endometrioma lesion microenvironment, combining 2D and 3D biomaterials tools with human menstrual effluent
specimens to investigate processes responsible for lesion initiation and invasion. To accomplish this goal, we
will first identify cues that inform adhesion of endometriotic epithelial and stromal cell cohorts responsible for
lesion initiation (Aim 1). Then we will define patterns of endometrioma invasion in response to the ovarian
microvascular environment (Aim 2). We will generate unprecedented data regarding variation of lesion initiation
and invasion not possible in vivo. Understanding how tissue tropism and ovarian vascular signals shape patterns
of lesion initiation and invasion is essential for the design of effective and equitable therapeutic strategies. Tissue
engineering models benchmarked here will also provide an essential foundation for future study of the influence
of chronic inflammatory signals on lesion persistence and recurrence.
Public Health Relevance Statement
NARRATIVE
Endometriosis affects nearly 10% of all menstruating people and is commonly associated with chronic pelvic
pain and infertility. Improved understanding of lesion initiation is necessary for the design of next-generation
therapeutic strategies. This project will use tissue engineering approaches to investigate processes
responsible for ovarian endometrioma lesion initiation and invasion using cells isolated from menstrual effluent.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
041544081
UEI
Y8CWNJRCNN91
Project Start Date
19-March-2025
Project End Date
31-December-2029
Budget Start Date
19-March-2025
Budget End Date
31-December-2025
Project Funding Information for 2025
Total Funding
$643,049
Direct Costs
$429,923
Indirect Costs
$213,126
Year
Funding IC
FY Total Cost by IC
2025
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$643,049
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01HD118600-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01HD118600-01
Patents
No Patents information available for 1R01HD118600-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01HD118600-01
Clinical Studies
No Clinical Studies information available for 1R01HD118600-01
News and More
Related News Releases
No news release information available for 1R01HD118600-01
History
No Historical information available for 1R01HD118600-01
Similar Projects
No Similar Projects information available for 1R01HD118600-01